1	Effects	Effect	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	intranasal	intranasal	_	_	_	_	_	_	_
4	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
5	on	on	_	_	_	_	_	_	_
6	endogenous	endogenous	_	_	_	_	_	_	_
7	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
8	peripheral	peripheral	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	central	central	_	_	_	_	_	_	_
11	function	function	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
2	are	be	_	_	_	_	_	_	_
3	among	among	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	most	most	_	_	_	_	_	_	_
6	potent	potent	_	_	_	_	_	_	_
7	antiinflammatory	antiinflammatory	_	_	_	_	_	_	_
8	agents	agent	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	can	can	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	used	use	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	treatment	treatment	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	rhinitis	rhinitis	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Their	their	_	_	_	_	_	_	_
2	mechanisms	mechanism	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	action	action	_	_	_	_	_	_	_
5	are	be	_	_	_	_	_	_	_
6	multiple	multiple	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	complex	complex	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	number	number	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	reports	report	_	_	_	_	_	_	_
14	describe	describe	_	_	_	_	_	_	_
15	significant	significant	_	_	_	_	_	_	_
16	systemic	systemic	_	_	_	_	_	_	_
17	effects	effect	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	locally	locally	_	_	_	_	_	_	_
20	administered	administer	_	_	_	_	_	_	_
21	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	order	order	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	evaluate	evaluate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	short-term	short-term	_	_	_	_	_	_	_
7	systemic	systemic	_	_	_	_	_	_	_
8	effects	effect	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	intranasally	intranasally	_	_	_	_	_	_	_
11	administered	administer	_	_	_	_	_	_	_
12	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	14	14	_	_	_	_	_	_	_
15	normal	normal	_	_	_	_	_	_	_
16	healthy	healthy	_	_	_	_	_	_	_
17	subjects	subject	_	_	_	_	_	_	_
18	were	be	_	_	_	_	_	_	_
19	treated	treat	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	two	two	_	_	_	_	_	_	_
22	doses	dose	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	either	either	_	_	_	_	_	_	_
25	budesonide	budesonide	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	BUD	BUD	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	or	or	_	_	_	_	_	_	_
30	fluticasone	fluticasone	_	_	_	_	_	_	_
31	propionate	propionate	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	FP	FP	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	for	for	_	_	_	_	_	_	_
36	2	2	_	_	_	_	_	_	_
37	weeks	week	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Before	before	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	at	at	_	_	_	_	_	_	_
5	regular	regular	_	_	_	_	_	_	_
6	intervals	interval	_	_	_	_	_	_	_
7	during	during	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	treatment	treatment	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	1	1	_	_	_	_	_	_	_
12	week	week	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	finally	finally	_	_	_	_	_	_	_
15	6	6	_	_	_	_	_	_	_
16	weeks	week	_	_	_	_	_	_	_
17	after	after	_	_	_	_	_	_	_
18	termination	termination	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	treatment	treatment	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	effects	effect	_	_	_	_	_	_	_
24	on	on	_	_	_	_	_	_	_
25	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
26	receptor	receptor	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	GR	GR	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	methallothionein	methallothionein	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	MTIIa	MTIIa	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	mRNA	mrna	_	_	_	_	_	_	_
36	expression	expression	_	_	_	_	_	_	_
37	levels	level	_	_	_	_	_	_	_
38	were	be	_	_	_	_	_	_	_
39	examined	examine	_	_	_	_	_	_	_
40	in	in	_	_	_	_	_	_	_
41	peripheral	peripheral	_	_	_	_	_	_	_
42	lymphocytes	lymphocyte	_	_	_	_	_	_	_
43	using	use	_	_	_	_	_	_	_
44	a	a	_	_	_	_	_	_	_
45	solution	solution	_	_	_	_	_	_	_
46	hybridization	hybridization	_	_	_	_	_	_	_
47	assay	assay	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	Serum	Serum	_	_	_	_	_	_	_
2	cortisol	cortisol	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	osteocalcin	osteocalcin	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	urinary	urinary	_	_	_	_	_	_	_
7	cortisol	cortisol	_	_	_	_	_	_	_
8	levels	level	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	also	also	_	_	_	_	_	_	_
11	determined	determine	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	An	an	_	_	_	_	_	_	_
2	insulin	insulin	_	_	_	_	_	_	_
3	tolerance	tolerance	_	_	_	_	_	_	_
4	test	test	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	ITT	ITT	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	performed	perform	_	_	_	_	_	_	_
10	at	at	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	end	end	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	second	second	_	_	_	_	_	_	_
16	week	week	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	treatment	treatment	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	at	at	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	end	end	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	6-week	6-week	_	_	_	_	_	_	_
26	washout	washout	_	_	_	_	_	_	_
27	period	period	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	no	no	_	_	_	_	_	_	_
30	statistically	statistically	_	_	_	_	_	_	_
31	significant	significant	_	_	_	_	_	_	_
32	change	change	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	cortisol	cortisol	_	_	_	_	_	_	_
35	response	response	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	peripheral	peripheral	_	_	_	_	_	_	_
3	lymphocytes	lymphocyte	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	GR	GR	_	_	_	_	_	_	_
6	mRNA	mRNA	_	_	_	_	_	_	_
7	levels	level	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	significantly	significantly	_	_	_	_	_	_	_
10	down-regulated	down-regulate	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	MTIIa	MTIIa	_	_	_	_	_	_	_
2	mRNA	mRNA	_	_	_	_	_	_	_
3	levels	level	_	_	_	_	_	_	_
4	increased	increase	_	_	_	_	_	_	_
5	significantly	significantly	_	_	_	_	_	_	_
6	.	.	_	_	_	_	_	_	_

1	Serum	Serum	_	_	_	_	_	_	_
2	osteocalcin	osteocalcin	_	_	_	_	_	_	_
3	decreased	decrease	_	_	_	_	_	_	_
4	significantly	significantly	_	_	_	_	_	_	_
5	during	during	_	_	_	_	_	_	_
6	treatment	treatment	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	both	both	_	_	_	_	_	_	_
9	BUD	BUD	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	FP	FP	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Serum	Serum	_	_	_	_	_	_	_
2	cortisol	cortisol	_	_	_	_	_	_	_
3	decreased	decrease	_	_	_	_	_	_	_
4	after	after	_	_	_	_	_	_	_
5	1	1	_	_	_	_	_	_	_
6	week	week	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	treatment	treatment	_	_	_	_	_	_	_
9	whereas	whereas	_	_	_	_	_	_	_
10	urinary	urinary	_	_	_	_	_	_	_
11	cortisol	cortisol	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	affected	affect	_	_	_	_	_	_	_
15	until	until	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	second	second	_	_	_	_	_	_	_
18	week	week	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	treatment	treatment	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	conclusion	conclusion	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	intranasal	intranasal	_	_	_	_	_	_	_
5	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
6	at	at	_	_	_	_	_	_	_
7	clinically	clinically	_	_	_	_	_	_	_
8	recommended	recommend	_	_	_	_	_	_	_
9	doses	dose	_	_	_	_	_	_	_
10	have	have	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	only	only	_	_	_	_	_	_	_
13	significant	significant	_	_	_	_	_	_	_
14	systemic	systemic	_	_	_	_	_	_	_
15	effects	effect	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	adrenal	adrenal	_	_	_	_	_	_	_
18	function	function	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	but	but	_	_	_	_	_	_	_
21	also	also	_	_	_	_	_	_	_
22	have	have	_	_	_	_	_	_	_
23	an	an	_	_	_	_	_	_	_
24	effect	effect	_	_	_	_	_	_	_
25	on	on	_	_	_	_	_	_	_
26	specific	specific	_	_	_	_	_	_	_
27	gene	gene	_	_	_	_	_	_	_
28	expression	expression	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	peripheral	peripheral	_	_	_	_	_	_	_
31	lymphocytes	lymphocyte	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	effects	effect	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	receptor-dependent	receptor-dependent	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	reversible	reversible	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	according	accord	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	serum	serum	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	urinary	urinary	_	_	_	_	_	_	_
14	cortisol	cortisol	_	_	_	_	_	_	_
15	levels	level	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	ITT	ITT	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	leave	leave	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
22	function	function	_	_	_	_	_	_	_
23	intact	intact	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	short-term	short-term	_	_	_	_	_	_	_
5	systemic	systemic	_	_	_	_	_	_	_
6	effects	effect	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	associated	associate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	any	any	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	noticeable	noticeable	_	_	_	_	_	_	_
15	side-effects	side-effect	_	_	_	_	_	_	_
16	usually	usually	_	_	_	_	_	_	_
17	observed	observe	_	_	_	_	_	_	_
18	during	during	_	_	_	_	_	_	_
19	long-term	long-term	_	_	_	_	_	_	_
20	treatment	treatment	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

